Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $11.28 and last traded at $11.25, with a volume of 115656 shares. The stock had previously closed at $10.93.
Analysts Set New Price Targets
MURGY has been the topic of several research reports. Barclays raised Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München to a "strong-buy" rating in a research report on Tuesday, January 28th. Berenberg Bank lowered Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a "strong-buy" rating to a "hold" rating in a research report on Friday, October 25th. Finally, UBS Group lowered Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a "strong-buy" rating to a "hold" rating in a research report on Thursday, December 19th.
Get Our Latest Stock Analysis on Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Stock Performance
The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.20. The firm has a 50-day simple moving average of $10.59 and a two-hundred day simple moving average of $10.49. The company has a market capitalization of $72.10 billion, a price-to-earnings ratio of 7.01, a price-to-earnings-growth ratio of 1.72 and a beta of 1.03.
About Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München
(
Get Free Report)
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.
See Also
Before you consider Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München wasn't on the list.
While Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
